ImPact Biotech

Targeted Treatment for Selective Tumor Ablation

Startup

ImPact Biotech is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 1996. Targeted Treatment for Selective Tumor Ablation. The company has raised a total of $2.7M across 1 funding round, currently at the Pre-Funding stage. The company has 11-50 employees. Core technologies: Biologicals, Cells.

With $2.7M in total funding, ImPact Biotech is a Pre-Funding-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.

$2.7M
Raised
1
Rounds
4
Team
1996
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsCells
At a Glance
In the News

6 articles covered by sources including www.globenewswire.com, finance.yahoo.com, www.bioworld.com, www.pharmaceutical-technology.com.

www.globenewswire.com · Sep 26, 2024
ImPact Biotech Announces 50% Enrollment in Phase 3 ENLIGHTED Clinical Trial of Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
Read article ↗
Frequently Asked Questions
What does ImPact Biotech do?

ImPact Biotech is focused on the development and launch of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, a targeted treatment for selective tumor ablation. Padeliporfin VTP therapy is a novel Oncology technology platform that comprises the intravenous delivery of an inactive drug, Padeliporfin, which is then precisely activated only in the tumor micro-environment by non-thermal laser light delivered via optical fiber(s). This results in the immediate occlusion of the tumor blood supply followed by self-propagating immunogenic cell death and immune activation with minimal effect on surrounding healthy tissues. ImPact Biotech holds exclusive rights from the Weizmann Institute of Science (WIS, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York), to develop and commercialize drugs and related technologies used in VTP.

How much funding has ImPact Biotech raised?

ImPact Biotech has raised $2.7M in total funding across 1 rounds. The company is currently at the Pre-Funding stage.

What sector is ImPact Biotech in?

ImPact Biotech operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is ImPact Biotech located?

ImPact Biotech is based in Ness Ziona, Israel, Center District.

View Full Profile Classic View Website ↗